NACB: Diabetes Mellitus

The National Academy of Clinical Biochemistry 
 
Laboratory Medicine Practice Guidelines

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus


Published Guidelines

Access to Table of Contents

Contributors and Sponsors

An expert committee drafted evidence-based recommendations for the use of laboratory analysis in patients with diabetes. An external panel of experts reviewed a draft of the guidelines, which were modified in response to the reviewers’ suggestions. A revised draft was posted on the Internet and was presented at the AACC Annual Meeting in July, 2000. The recommendations were modified again in response to oral and written comments. The guidelines were reviewed by the Professional Practice Committee of the American Diabetes Association.

The material in this monograph represents the opinions of the editors and does not represent the official position of the National Academy of Clinical Biochemistry or any of the co-sponsoring organizations. The National Academy of Clinical Biochemistry is the official academy of the American Association for Clinical Chemistry.

Single copies for personal use may be printed from authorized Internet sources such as the NACB's Home Page , provided it is printed in its entirety, including this notice. Printing of selected portions of the document is also permitted for personal use provided the user also prints and attaches the title page and cover pages to the selected reprint or otherwise clearly identifies the reprint as having been produced by the NACB. Otherwise, this document may not be reproduced in whole or in part, stored in a retrieval system, translated into another language, or transmitted in any form without express written permission of the National Academy of Clinical Biochemistry (NACB, 2101 L Street, N.W., Washington, DC 20037-1526). Permission will ordinarily be granted provided the logo of the NACB and the following notice appear prominently at the front of the document: Reproduced (translated) with permission of the National Academy of Clinical Biochemistry, Washington, DC

Single or multiple copies may also be purchased from the NACB at the address above or by ordering through the Home Page (http://www.nacb.org/).

David B. Sacks, David E. Bruns, David E. Goldstein, Noel K. Maclaren, Jay M. McDonald, and Marian Parrott (Editors)

©2002 by the National Academy of Clinical Biochemistry.


We gratefully acknowledge the following for:

Manuscript Review

John Eckfeldt
University of Minnesota, Minneapolis, MN

George Eisenbarth, University of Colorado Health Sciences Center, Denver, CO

Callum Fraser
Ninewells Hospital and Medical School, Dundee, Scotland

Len Harrison
Walter and Eliza Hall Institute, Royal Melbourne Hospital, Melbourne, Australia

Ake Lernmark
University of Washington, Seattle, WA

Randie Little
University of Missouri, Columbia, MO

Kor Miedema
Ziekenhuis De Weezenlanden, JW Zwolle, The Netherlands

David Nathan
Harvard Medical School, Boston, MA

Michael Steffes
University of Minnesota, Minneapolis, MN.

Valuable comments:

Jim Boyd, Robert Dufour, Steven Johnson, Gerald Kost, Matthew Meerkin, Patricia Mueller, Gary Myers, Kimberly Porter, William Roberts, and Sverre Sandberg.

Publication of these guidelines was supported by grants from American Association for Clinical Chemistry  and the following:

Contributing Corporate Sponsors:

Abbott Diagnostics
PerkinElmer Life Sciences


Participating Corporate Sponsors:

Beckman Coulter
Bio-Rad Laboratories
Diagnostic Products Corporation
Tosoh Medics, Inc.
Page Access: